Abstract
The effects of α- and β-adrenergic blocking agents on the serum prolactin levels of six women with hyperprolactinemia and galactorrhea were investigated. There was no indication that pituitary adenomas were etiologic agents for the hyperprolactinemia. Serum prolactin could be lowered with orall-dopa. When intravenous phentolamine (an α-adrenergic blocking agent) or intravenous propranolol (a β-adrenergic blocking agent) were administered for 1 hour, there was no significant change in serum prolactin levels.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
